Largest pharmaceutical companies by cash on hand
Cash and cash equivalents at the end of the latest fiscal year. Short-term investments are not counted.
Johnson & Johnson leads the 61 pharmaceutical companies ranked by cash on hand, at HUF 6.61T, ahead of Merck & Co (HUF 4.89T) and Novartis (HUF 3.84T). Figures as of 19 Nov 2026, 09:52 UTC, from Yahoo Finance quotes.
Key facts
- Companies ranked
- 61
- First
- Johnson & JohnsonHUF 6.61T
- Median
- HUF 192.4B
- Combined market value
- HUF 1697.7T
- Countries
- 10
Market values as of .
All countries▾
All sectors▾
Pharmaceuticals▾
| # | Company | Cash on hand ↓ | Market cap | Price | Today | 1 year | Price, 30 days | Country |
|---|---|---|---|---|---|---|---|---|
| 1 | Johnson & JohnsonJNJ · Health Care | HUF 6.61T | HUF 220.3T | HUF 91,512.39 | 2.15% down | 38% up | ||
| 2 | Merck & CoMRK · Health Care | HUF 4.89T | HUF 113.98T | HUF 46,236.07 | 3.90% down | 51% up | ||
| 3 | NovartisNVS · Health Care | HUF 3.84T | HUF 98.37T | HUF 52,085.22 | 2.46% down | 25% up | ||
| 4 | Bristol-Myers SquibbBMY · Health Care | HUF 3.43T | HUF 40.86T | HUF 19,987.09 | 2.92% down | 34% up | ||
| 5 | Abbott LaboratoriesABT · Health Care | HUF 2.86T | HUF 60.72T | HUF 35,061.29 | 0.22% down | 17% down | ||
| 6 | SanofiSNY · Health Care | HUF 2.85T | HUF 37.97T | HUF 15,812.48 | 0.86% down | 4% down | ||
| 7 | Eli LillyLLY · Health Care | HUF 2.44T | HUF 413.33T | HUF 464,021.86 | 2.32% down | 35% up | ||
| 8 | AstraZenecaAZN · Health Care | HUF 1.92T | HUF 93.04T | HUF 59,988.10 | 1.93% down | 2% up | ||
| 9 | AbbVieABBV · Health Care | HUF 1.75T | HUF 169.65T | HUF 95,978.95 | 2.33% down | 26% up | ||
| 10 | Vertex PharmaceuticalsVRTX · Health Care | HUF 1.71T | HUF 45.64T | HUF 180,021.35 | 0.42% up | 27% up | ||
| 11 | BeOne MedicinesONC · Health Care | HUF 1.53T | HUF 15.47T | HUF 135,439.68 | 2.34% down | 17% up | ||
| 12 | GSKGSK · Health Care | HUF 1.51T | HUF 32.68T | HUF 16,302.43 | 1.34% down | 6% up | ||
| 13 | Novo NordiskNVO · Health Care | HUF 1.32T | HUF 58.32T | HUF 13,231.88 | 3.12% down | 17% down | ||
| 14 | Takeda PharmaceuticalTAK · Health Care | HUF 1.25T | HUF 22.8T | HUF 7,137.77 | 1.71% down | 54% up | ||
| 15 | Teva Pharmaceutical IndustriesTEVA · Health Care | HUF 1.19T | HUF 16.54T | HUF 14,171.50 | 0.92% down | 74% up | ||
| 16 | Regeneron PharmaceuticalsREGN · Health Care | HUF 1.05T | HUF 32.82T | HUF 317,300.01 | 1.28% down | 36% up | ||
| 17 | ZoetisZTS · Health Care | HUF 775.9B | HUF 11.67T | HUF 28,715.50 | 2.50% up | 29% down | ||
| 18 | GenmabGMAB · Health Care | HUF 575.5B | HUF 10.55T | HUF 17,104.46 | 1.91% down | 70% up | ||
| 19 | Alnylam PharmaceuticalsALNY · Health Care | HUF 556.1B | HUF 6.72T | HUF 50,135.50 | 4.54% down | 66% down | ||
| 20 | United TherapeuticsUTHR · Health Care | HUF 522.5B | HUF 8.25T | HUF 193,743.18 | 1.16% down | 23% up | ||
| 21 | Roivant SciencesROIV · Health Care | HUF 476.3B | HUF 9.42T | HUF 12,996.97 | 0.05% up | 90% up | ||
| 22 | Jazz PharmaceuticalsJAZZ · Health Care | HUF 467.1B | HUF 5.34T | HUF 83,146.41 | 2.93% up | 37% up | ||
| 23 | ViatrisVTRS · Health Care | HUF 443.8B | HUF 7.8T | HUF 6,805.54 | 0.83% down | 96% up | ||
| 24 | BioMarin PharmaceuticalBMRN · Health Care | HUF 440.2B | HUF 3.99T | HUF 20,614.62 | 4.99% up | 11% up | ||
| 25 | PfizerPFE · Health Care | HUF 383.2B | HUF 53.67T | HUF 9,416.35 | 1.44% down | 14% up | ||
| 26 | PTC TherapeuticsPTCT · Health Care | HUF 330.4B | HUF 1.69T | HUF 20,211.92 | 0.22% down | 20% down | ||
| 27 | GrifolsGRFS · Health Care | HUF 307.2B | HUF 1.93T | HUF 2,842.35 | 1.85% down | 1% up | ||
| 28 | Legend BiotechLEGN · Health Care | HUF 302.7B | HUF 1.06T | HUF 5,453.16 | 0.87% up | 42% down | ||
| 29 | Ascendis PharmaASND · Health Care | HUF 229.4B | HUF 5.95T | HUF 90,717.07 | 0.32% down | 28% up | ||
| 30 | Royalty PharmaRPRX · Health Care | HUF 207.6B | HUF 13.25T | HUF 23,044.21 | 0.01% down | 78% up | ||
| 31 | ABIVAXABVX · Health Care | HUF 192.4B | HUF 2.46T | HUF 28,131.59 | 2.11% up | 27% down | ||
| 32 | BridgeBio PharmaBBIO · Health Care | HUF 191.3B | HUF 5.1T | HUF 26,178.52 | 1.58% up | 17% up | ||
| 33 | Elanco Animal HealthELAN · Health Care | HUF 182.9B | HUF 4.48T | HUF 8,959.96 | 3.29% up | 20% up | ||
| 34 | InsmedINSM · Health Care | HUF 171.3B | HUF 8.82T | HUF 40,202.36 | 1.69% down | 40% down | ||
| 35 | AlkermesALKS · Health Care | HUF 130.4B | HUF 2.64T | HUF 15,721.88 | 3.08% up | 58% up | ||
| 36 | Ionis PharmaceuticalsIONS · Health Care | HUF 124.9B | HUF 1.53T | HUF 9,191.51 | 1.59% up | 64% down | ||
| 37 | Praxis Precision MedicinesPRAX · Health Care | HUF 119.9B | HUF 2.86T | HUF 102,415.36 | 0.04% up | 61% up | ||
| 38 | Belite BioBLTE · Health Care | HUF 118.4B | HUF 2.13T | HUF 52,427.51 | 0.94% down | 31% up | ||
| 39 | Axsome TherapeuticsAXSM · Health Care | HUF 108.4B | HUF 2.37T | HUF 44,967.59 | 1.43% down | 7% down | ||
| 40 | Cogent BiosciencesCOGT · Health Care | HUF 104.7B | HUF 1.62T | HUF 9,332.45 | 0.14% down | 20% down | ||
| 41 | Mirum PharmaceuticalsMIRM · Health Care | HUF 99.6B | HUF 2.03T | HUF 31,037.70 | 0.59% up | 31% up | ||
| 42 | Amneal PharmaceuticalsAMRX · Health Care | HUF 94.6B | HUF 2.56T | HUF 7,342.47 | 3.60% up | 83% up | ||
| 43 | Definium TherapeuticsDFTX · Health Care | HUF 86.5B | HUF 1.34T | HUF 9,772.06 | 0.88% down | 169% up | ||
| 44 | Arrowhead PharmaceuticalsARWR · Health Care | HUF 76B | HUF 2.05T | HUF 14,466.81 | 0.28% up | 10% up | ||
| 45 | Summit TherapeuticsSMMT · Health Care | HUF 75.6B | HUF 2.82T | HUF 3,523.58 | 1.59% down | 36% down | ||
| 46 | Madrigal PharmaceuticalsMDGL · Health Care | HUF 66.7B | HUF 3.1T | HUF 133,587.29 | 5.67% down | 24% down | ||
| 47 | Ligand PharmaceuticalsLGND · Health Care | HUF 58.7B | HUF 2.01T | HUF 100,240.80 | 1.67% up | 43% up | ||
| 48 | Kiniksa Pharmaceuticals InternationalKNSA · Health Care | HUF 55.6B | HUF 2.51T | HUF 31,896.78 | 0.06% down | 126% up | ||
| 49 | Dr. Reddy's LaboratoriesRDY · Health Care | HUF 54.9B | HUF 4.19T | HUF 5,026.97 | 1.28% up | 5% up | ||
| 50 | Protagonist TherapeuticsPTGX · Health Care | HUF 43.1B | HUF 2.79T | HUF 42,672.23 | 2.00% up | 46% up | ||
| 51 | CytokineticsCYTK · Health Care | HUF 41.1B | HUF 2.4T | HUF 17,221.91 | 0.64% down | 20% down | ||
| 52 | Corcept TherapeuticsCORT · Health Care | HUF 40.4B | HUF 2.49T | HUF 22,748.90 | 3.25% down | 8% down | ||
| 53 | Travere TherapeuticsTVTX · Health Care | HUF 31.2B | HUF 1.62T | HUF 16,859.49 | 1.68% down | 44% up | ||
| 54 | Spyre TherapeuticsSYRE · Health Care | HUF 28.8B | HUF 3.23T | HUF 34,047.85 | 8.15% up | 286% up | ||
| 55 | TG TherapeuticsTGTX · Health Care | HUF 26.6B | HUF 3.35T | HUF 22,188.48 | 5.44% up | 107% up | ||
| 56 | ErascaERAS · Health Care | HUF 24.8B | HUF 1.62T | HUF 4,617.57 | 0.94% down | 403% up | ||
| 57 | Edgewise TherapeuticsEWTX · Health Care | HUF 20.5B | HUF 1.52T | HUF 13,882.90 | 1.59% down | 88% up | ||
| 58 | Rhythm PharmaceuticalsRYTM · Health Care | HUF 18.2B | HUF 2.77T | HUF 39,947.32 | 2.08% up | 13% up | ||
| 59 | Dianthus TherapeuticsDNTH · Health Care | HUF 17.1B | HUF 1.59T | HUF 28,181.92 | 3.45% down | 113% up | ||
| 60 | Oruka TherapeuticsORKA · Health Care | HUF 15.8B | HUF 2.18T | HUF 32,128.33 | 0.60% down | 241% up | ||
| 61 | VeradermicsMANE · Health Care | HUF 7.3B | HUF 1.77T | HUF 41,900.39 | 0.62% down | 233% up |
Sources: share prices and market values from Yahoo Finance; sector, country and category from each company's SEC registration; annual figures from the reports companies file with the SEC.
Market value is share price × shares outstanding, from Yahoo Finance; prices may be delayed 15 minutes or more and the ranking refreshes about every 20 minutes. The list covers companies with shares listed in the US, which includes foreign companies listed through ADRs but not ones listed only abroad. Sector, category and country come from each company's SEC registration. Cash on hand is from each company's latest annual report filed with the SEC (collected 2026-11-12); a company that reports in another currency is converted to US dollars at the exchange rate of that day, not of the period. Sums are converted from US dollars at today's exchange rate (1 USD = 335.6 HUF).
Questions and answers
Which pharmaceutical companies rank first by cash on hand?
Johnson & Johnson (HUF 6.61T), Merck & Co (HUF 4.89T) and Novartis (HUF 3.84T) are the top three of the 61 pharmaceutical companies ranked by cash on hand as of 19 Nov 2026, 09:52 UTC.
How many pharmaceutical companies are in this ranking?
61 are ranked by cash on hand.
What are these pharmaceutical companies worth together?
The 61 pharmaceutical companies ranked by cash on hand have a combined market value of HUF 1697.7T as of 19 Nov 2026, 09:52 UTC.
What does ranking by cash on hand measure?
Cash and cash equivalents at the end of the latest fiscal year. Short-term investments are not counted.
Learn how this ranking works
All markets guides →- Altman Z-score: formula, zones and where it fails
The Altman Z-score is a weighted sum of five financial ratios that Edward Altman fitted in 1968 to separate companies that went bankrupt from those that did not. Funkfolio reads above 2.99 as the safe zone, below 1.81 as the distress zone, and between them a grey zone. It does not suit banks or insurers.
- Market cap vs enterprise value: what is the difference?
Market capitalization is the value of a company's shares. Enterprise value is market cap plus debt, minus cash: roughly what it would cost to buy the whole business and settle its borrowings. Two companies with the same $50 billion market cap can have very different enterprise values if one owes $20 billion and the other holds $20 billion in cash.
- How an ETF's size is measured: AUM, NAV and creation units
An ETF's size is usually measured by its assets under management (AUM), the fund's net assets: everything it holds minus what it owes. That equals net asset value per share times shares outstanding. AUM grows when the holdings rise in value and when large institutions create new shares, and shrinks when they redeem them.
Cite this page
Funkfolio, “Largest pharmaceutical companies by cash on hand”, data as of 19 November 2026. https://funkfolio.com/companies/category/pharmaceuticals?by=cash-on-hand
Underlying data: Yahoo Finance; SEC EDGAR.